Background
Diagramm, a German company marketing printed products, sold thermoplastic identification wristbands manufactured by ZEBRA Technologies to a German nursing service. The wristbands, supplied completely blank, are designed to be printed with patient identifiers such as name, birth date, and hospital file numbers. ZEBRA’s promotional materials claimed the wristbands improve patient safety by helping healthcare staff verify the “five rights” (right patient, right medication, right dose, right time, route of administration) and reduce medical errors, which the manufacturer noted are the third leading cause of death.
Zentrale zur Bekämpfung unlauteren Wettbewerbs, a German consumer protection association, argued that Diagramm violated Regulation 2017/745 by selling the wristbands without CE marking or an EU declaration of conformity, as required for medical devices. Zentrale sued under German unfair competition law. The referring court asked whether the wristbands constitute medical devices and whether the promotional materials establish an intended medical purpose under Article 2(12) of the regulation.
The Court’s Holding
The Court of Justice held that the identification wristbands cannot be classified as medical devices under Regulation 2017/745, even in their printable form. The court established that while manufacturer intent and promotional materials can contribute to determining “intended purpose,” not all promotional information is decisive. Contextual information encouraging general best practices—such as the benefits of reliable patient identification systems—differs from information about actual medical use of a product.
The court reasoned that the wristbands’ sole objective is administrative patient identification, not a specific medical function. Because the wristbands were supplied blank and performed no therapeutic, diagnostic, or other medical function enumerated in Article 2(1), they could not be medical devices. The absence of clinical evaluation, medical data on labels or in instructions, and the fact that identical identification objectives could be achieved through non-medical means (nameplates, badges, identity documents) all confirmed that the wristbands have no direct influence on diagnostic or therapeutic activities and perform purely administrative functions.
Key Takeaways
- A product used in a healthcare setting is not automatically a medical device; it must serve a direct, specific medical purpose such as diagnosis, treatment, or monitoring
- Promotional materials making general safety claims do not establish a medical “intended purpose” if the product itself performs only administrative or facilitating functions
- The “intended purpose” of a device must be assessed both from manufacturer statements and from the objective functions the device actually performs
- Products replaceable by non-medical alternatives for the same purpose—such as identification wristbands replaceable by nameplates—fall outside medical device regulation
Why It Matters
This ruling defines a critical boundary in EU medical device regulation. It prevents manufacturers and distributors from being caught in regulatory traps over routine products used incidentally in healthcare settings. The decision clarifies that Regulation 2017/745 applies only to products with direct medical functionality, not to ancillary administrative tools that support medical activities. A healthcare facility tool that merely facilitates identification or communication, even if it reduces medical errors indirectly, need not meet the demanding CE marking and conformity requirements imposed on genuine medical devices.
The ruling has practical significance for hospital supply chains, medical equipment vendors, and product compliance strategies. Companies selling administrative or clerical products to healthcare providers can now rely on objective functional analysis rather than fear that promotional materials claiming safety benefits will trigger medical device classification and costly regulatory compliance obligations.